FDA chief scientist Namandjé Bumpus has been named as principal deputy commissioner, replacing long-serving Janet Woodcock when she steps down early next year.
Swedish contract development and manufacturing organisation (CDMO) Recipharm has appointed former Nestlé Health Sciences’ chief executive Greg Behar as its new CEO, replac
After 18 years in charge, BioMarin Pharma’s chief executive and chairman, Jean-Jacques Bienaimé, has announced his retirement, with a high-powered replacement already line
Novartis’ former chief medical officer John Tsai has returned to a senior position in biopharma, taking the role of chief executive of UK start-up Forcefield Therapeutics.
Professor Sir Jonathan Van-Tam, one of the key faces in the UK government's COVID-19 response, has taken a job as a senior medical consultant at vaccine developer Moderna.
A pharma company’s core mission is to improve patient outcomes. This hinges on effectively influencing HCP clinical behaviour and driving disease education.